Posted inStock Dow futures slip 214 points amid Fed jitters: 5 things to know before Wall Street opens Dow futures were under pressure on Friday, falling about 214 points, roughly 0.5% as investors… November 14, 2025 Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inEconomy Tesla agrees to first deal to build China’s largest grid-scale battery power plant Tesla has inked its first deal to build a grid-scale battery power plant in China… June 21, 2025
Posted inStock GMS stock jumps 29% on takeover interest from Home Depot, QXO, analysts raise PTs Shares of GMS Inc. soared on Friday as the building-products distributor became the centre of… June 20, 2025
Posted inStock Japan’s rice price surge: what’s driving it and why it could spark a political crisis Japan’s rice prices are facing their most severe shock in more than half a century,… June 20, 2025
Posted inStock Foxconn and Nvidia to deploy humanoid robots in AI server factory: report Taiwan’s Foxconn and U.S. chipmaker Nvidia are in advanced discussions to deploy humanoid robots at… June 20, 2025
Posted inStock US stocks climb higher at open: Dow jones jumps 150 pts, Nasdaq up 0.6% US equity markets advanced on Friday after Federal Reserve Governor Christopher Waller said inflation was… June 20, 2025
Posted inStock Apollo backs £4.5bn loan for delayed Hinkley Point C nuclear plant One of Britain’s most delayed and expensive infrastructure projects, the Hinkley Point C nuclear plant,… June 20, 2025
Posted inStock Audi weighs $4.6 billion US plant amid tariff pressure from Trump According to a report from the German publication Spiegel, Audi is considering plans to build… June 20, 2025
Posted inStock Tesla stock gains ahead of robotaxi launch: analyst sees 50% upside ahead Tesla shares are gaining ground as investor excitement builds ahead of the company’s long-anticipated robotaxi… June 20, 2025
Posted inStock BofA raises STOXX 600 target amid resilient global growth, warns on Mideast risks Bank of America Global Research boosted its year-end projection for the STOXX 600 index to… June 20, 2025
Posted inStock XRP price stuck under $3: can it finally break through? XRP’s price briefly surged past the $3.00 mark in January 2025, but has failed to… June 20, 2025